Personalised prophylaxis with simoctocog alfa versus standard emicizumab prophylaxis in haemophilia A, a matching-adjusted indirect comparison

被引:0
|
作者
Kessler, C. M. [1 ]
Corrales-Medina, F. F. [2 ,3 ]
MannuccioMannucci, P. [4 ]
Astermark, J. [5 ,6 ]
Tarantino, M. D. [7 ]
机构
[1] Georgetown Univ, Lombardi Comprehens Canc Ctr, Med Ctr, Washington, DC USA
[2] Univ Miami, Div Pediat Hematol Oncol, Dept Pediat, Miller Sch Med, Miami, FL USA
[3] Univ Miami, Hemophilia Treatment Ctr, Miami, FL USA
[4] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy
[5] Lund Univ, Dept Translat Med, Malmo, Sweden
[6] Skane Univ Hosp, Dept Hematol Oncol & Radiat Phys, Malmo, Sweden
[7] Bleeding & Clotting Disorders Inst, Peoria, IL USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PO042
引用
收藏
页码:55 / 55
页数:1
相关论文
共 50 条
  • [1] Personalised prophylaxis with simoctocog alfa versus standard prophylaxis with efanesoctocog alfa in haemophilia A, a matching-adjusted indirect comparison
    Kessler, C. M.
    Corrales-Medina, F. F.
    MannuccioMannucci, P.
    Astermark, J.
    Tarantino, M. D.
    HAEMOPHILIA, 2024, 30 : 54 - 55
  • [2] MATCHING ADJUSTED INDIRECT COMPARISONS BETWEEN PERSONALISED PROPHYLAXIS WITH SIMOCTOCOG ALFA VERSUS STANDARD PROPHYLAXIS WITH EMICIZUMAB IN ADULTS WITH SEVERE HAEMOPHILIA A
    Kessler, C.
    Corrales-Medina, F.
    Tarantino, M.
    HAEMOPHILIA, 2023, 29 : 33 - 34
  • [3] Matching-Adjusted Indirect Comparison between Personalized Prophylaxis with Simoctocog Alfa Versus Standard Prophylaxis with Emicizumab in Adults with Hemophilia a
    Kessler, Craig
    Corrales-Medina, Fernando F.
    Mannucci, Pier Mannuccio
    Tarantino, Michael D.
    BLOOD, 2023, 142
  • [4] Matching-Adjusted Indirect Comparison of Personalized Prophylaxis with Simoctocog Alfa Versus Standard Prophylaxis with Efanesoctocog Alfa in Adults with Severe Hemophilia a
    Kessler, Craig
    Corrales-Medina, Fernando F.
    Mannucci, Pier Mannuccio
    Tarantino, Michael D.
    BLOOD, 2023, 142
  • [5] Matching-adjusted indirect comparison of bleeding outcomes in severe haemophilia A: Comparing valoctocogene roxaparvovec gene therapy, emicizumab prophylaxis, and FVIII replacement prophylaxis
    Astermark, Jan
    Buckner, Tyler W.
    Frenzel, Laurent
    Hatswell, Anthony J.
    You, Xiaojun
    Liu, Hai
    Goodman, Erin
    Santos, Sandra
    Hawes, Charles
    Hinds, David
    Klamroth, Robert
    HAEMOPHILIA, 2023, 29 (04) : 1087 - 1094
  • [6] Matching Adjusted Indirect Comparisons of Personalized Prophylaxis with Simoctocog Alfa Versus Efmoroctocog Alfa, Damoctocog Alfa Pegol and Rurioctocog Alfa Pegol in Patients with Hemophilia a
    Kessler, Craig M.
    Tiede, Andreas
    BLOOD, 2022, 140 : 2755 - 2756
  • [7] Clinical efficacy of simoctocog alfa versus extended half-life recombinant FVIII concentrates in hemophilia A patients undergoing personalized prophylaxis using a matching-adjusted indirect comparison method
    Kessler, Craig M.
    Corrales-Medina, Fernando F.
    Mannucci, Pier Mannuccio
    Jimenez-Yuste, Victor
    Tarantino, Michael D.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 111 (05) : 757 - 767
  • [8] MATCHING-ADJUSTED INDIRECT COMPARISON OF THE EFFICACY AND CONSUMPTION OF LONOCTOCOG ALFA VS TWO RECOMBINANT FVIII FOR THE PROPHYLAXIS AND TREATMENT OF BLEEDING EPISODES IN SEVERE HAEMOPHILIA A
    Santos, S.
    Ramos, D.
    Vandewalle, B.
    Rabiais, S.
    Mota, M.
    Andreozzi, V.
    HAEMOPHILIA, 2020, 26 : 58 - 58
  • [9] MATCHING-ADJUSTED INDIRECT TREATMENT COMPARISON BETWEEN LANADELUMAB AND BEROTRALSTAT FOR HEREDITARY ANGIOEDEMA PROPHYLAXIS
    Watt, M.
    Malmenas, M.
    Romanus, D.
    Haeussler, K.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S26 - S26
  • [10] EFFICACY OF RFVIIIFC VERSUS EMICIZUMAB FOR THE TREATMENT OF PATIENTS WITH HAEMOPHILIA A WITHOUT INHIBITORS: MATCHING-ADJUSTED INDIRECT COMPARISON OF A-LONG AND HAVEN TRIALS
    Klamroth, R.
    Wojciechowski, P.
    Aballea, S.
    Diamand, F.
    Hakimi, Z.
    Nazir, J.
    Abad-Franch, L.
    Lethagen, S.
    Santagostino, E.
    Tarantino, M.
    VALUE IN HEALTH, 2020, 23 : S742 - S742